Expression of bmi-1 in Lung Cancer
Author Information
Author(s): Vonlanthen S, Heighway J, Altermatt H J, Gugger M, Kappeler A, Borner M M, Lohuizen M van, Betticher D C
Primary Institution: University of Bern
Hypothesis
The study aims to assess the expression of bmi-1 in resectable non-small cell lung cancer in association with p16 and p14ARF.
Conclusion
The study found that 58% of resectable non-small cell lung cancer cases exhibit moderate to high levels of bmi-1 protein, which correlates with low levels of p16 and p14ARF.
Supporting Evidence
- 58% of resectable NSCLC exhibit moderate-high levels of bmi-1 protein.
- Tumours with moderate or strong bmi-1 expression were more likely to have low levels of p16 and p14ARF.
- The inverse correlation of bmi-1 and the INK4 locus proteins expression supports a possible role for bmi-1 misregulation in lung carcinogenesis.
Takeaway
This study looked at a protein called bmi-1 in lung cancer and found that many tumors have a lot of it, which might be linked to other important proteins that help control cell growth.
Methodology
The study used immunohistochemistry for protein expression and comparative multiplex PCR for gene amplification analysis.
Participant Demographics
The study included 48 patients with resectable non-small cell lung cancer, with various tumor types and stages.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website